Federal contractor · CAMBRIDGE, MA

SPERO THERAPEUTICS, INC.

SPERO THERAPEUTICS, INC. received -$537.2K in federal contract obligations in FY2026, on 2 awards (−108% vs FY2025). Since FY2017: $62.5M. Its largest customer was National Institutes of Health ($0).

Obligations · FY2026
-$537.2K
New awards
2
Sole-source
—
Single offer
—
UEI
NX34PL7NZW24
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 2MFY2017
  2. 16.2MFY2018
  3. 2.7MFY2019
  4. 0FY2020
  5. 2.1MFY2021
  6. 12.9MFY2022
  7. 5MFY2023
  8. 15.8MFY2024
  9. 6.4MFY2025
  10. -537.2KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$00.0%
    1 awards
  2. Office of Assistant Secretary for Preparedness and Response-$537.2K0.0%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Largest awards

  1. IGF::OT::IGF$49.2M
    Office of Assistant Secretary for Preparedness and Response· Middlesex County, MA· Research & development· Jul 12, 2018 – Jul 6, 2026· 75A50118C00015
  2. TO ADVANCE CLINICAL AND NON-CLINICAL DEVELOPMENT OF AN ANTIBIOTIC CANDIDATE.$10.5M
    National Institutes of Health· Middlesex County, MA· Research & development· May 12, 2021 – Jul 20, 2026· 75N93021C00022

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

SPERO THERAPEUTICS, INC. received $0 in federal assistance in FY2026, on 0 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
0
Since FY2021
-$12.05

Assistance by fiscal year

  1. 0FY2021
  2. -12.1FY2023

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2023.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. SCYNEXIS INC$18.5M
    JERSEY CITY, NJ · 84% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services
  2. GIGAGEN INC$19.6M
    SAN CARLOS, CA · 84% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services
  3. OSIVAX$20.2M−100% in FY2026
    PARIS 8, FRA · 84% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.